March 03, 2021
Genome BC has established a leading role in scientific research in the country and has focused attention in the last year on learning about the pandemic to advance treatment techniques and to prepare us for future health threats. Pascal Spothelfer, Genome BC’s President and CEO, talks to BIV publisher and editor-in-chief Kirk LaPointe about the non-profit organization’s contributions to the genomic understanding of COVID-19.
